Mutagenetix > Incidental Mutation

Incidental Mutation 'R5640:B4galt2'

440589

Institutional Source

Beutler Lab

Gene Symbol

B4galt2

Ensembl Gene

ENSMUSG00000028541

Gene Name

UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2

Synonyms

MMRRC Submission

043289-MU

Accession Numbers

Essential gene?

Probably non essential (E-score: 0.210) question?

Stock #

R5640 (G1)

Quality Score

225

Status

Not validated

Chromosome

Chromosomal Location

117730197-117740759 bp(-) (GRCm39)

Type of Mutation

missense

DNA Base Change (assembly)

T to G at 117731195 bp (GRCm39)

Zygosity

Heterozygous

Amino Acid Change

Asparagine to Threonine at position 322 (N322T)

Ref Sequence

ENSEMBL: ENSMUSP00000102029 (fasta)

Gene Model

predicted gene model for transcript(s): [ENSMUST00000030266] [ENSMUST00000030269] [ENSMUST00000063857] [ENSMUST00000084325] [ENSMUST00000106421] [ENSMUST00000106422] [ENSMUST00000164853] [ENSMUST00000149168] [ENSMUST00000131938] [ENSMUST00000166325] [ENSMUST00000171052] [ENSMUST00000167287] [ENSMUST00000153358] [ENSMUST00000167443]

AlphaFold

Q9Z2Y2

Predicted Effect

probably benign
Transcript: ENSMUST00000030266
AA Change: N322T

PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)

SMART Domains

Protein: ENSMUSP00000030266
Gene: ENSMUSG00000028541
AA Change: N322T

Domain	Start	End	E-Value	Type
transmembrane domain	13	35	N/A	INTRINSIC
Pfam:Glyco_transf_7N	94	228	4.2e-59	PFAM
Pfam:Glyco_transf_7C	232	310	2.1e-32	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000030269

SMART Domains

Protein: ENSMUSP00000030269
Gene: ENSMUSG00000028542

Domain	Start	End	E-Value	Type
Pfam:SNF	27	562	5.1e-234	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000063857

SMART Domains

Protein: ENSMUSP00000066102
Gene: ENSMUSG00000028542

Domain	Start	End	E-Value	Type
Pfam:SNF	27	562	5.1e-234	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000084325
AA Change: N322T

PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)

SMART Domains

Protein: ENSMUSP00000081352
Gene: ENSMUSG00000028541
AA Change: N322T

Domain	Start	End	E-Value	Type
transmembrane domain	13	35	N/A	INTRINSIC
Pfam:Glyco_transf_7N	94	230	1.9e-47	PFAM
Pfam:Glyco_transf_7C	232	310	2.6e-32	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000106421
AA Change: N322T

PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)

SMART Domains

Protein: ENSMUSP00000102029
Gene: ENSMUSG00000028541
AA Change: N322T

Domain	Start	End	E-Value	Type
transmembrane domain	13	35	N/A	INTRINSIC
Pfam:Glyco_transf_7N	94	230	1.9e-47	PFAM
Pfam:Glyco_transf_7C	232	310	2.6e-32	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000106422

SMART Domains

Protein: ENSMUSP00000102030
Gene: ENSMUSG00000078588

Domain	Start	End	E-Value	Type
low complexity region	17	46	N/A	INTRINSIC
coiled coil region	133	158	N/A	INTRINSIC
low complexity region	254	266	N/A	INTRINSIC

Predicted Effect

noncoding transcript
Transcript: ENSMUST00000130758

Predicted Effect

noncoding transcript
Transcript: ENSMUST00000170733

Predicted Effect

noncoding transcript
Transcript: ENSMUST00000154439

Predicted Effect

probably benign
Transcript: ENSMUST00000164853

SMART Domains

Protein: ENSMUSP00000132114
Gene: ENSMUSG00000078588

Domain	Start	End	E-Value	Type
low complexity region	17	46	N/A	INTRINSIC
coiled coil region	133	158	N/A	INTRINSIC
low complexity region	254	266	N/A	INTRINSIC

Predicted Effect

probably benign
Transcript: ENSMUST00000149168

SMART Domains

Protein: ENSMUSP00000129359
Gene: ENSMUSG00000028542

Domain	Start	End	E-Value	Type
low complexity region	91	116	N/A	INTRINSIC

Predicted Effect

probably benign
Transcript: ENSMUST00000131938

Predicted Effect

probably benign
Transcript: ENSMUST00000166325

SMART Domains

Protein: ENSMUSP00000131493
Gene: ENSMUSG00000078588

Domain	Start	End	E-Value	Type
coiled coil region	33	57	N/A	INTRINSIC
low complexity region	61	90	N/A	INTRINSIC

Predicted Effect

probably benign
Transcript: ENSMUST00000171052

SMART Domains

Protein: ENSMUSP00000129502
Gene: ENSMUSG00000078588

Domain	Start	End	E-Value	Type
Pfam:CCDC24	21	201	3.9e-67	PFAM
low complexity region	282	294	N/A	INTRINSIC

Predicted Effect

probably benign
Transcript: ENSMUST00000167287

SMART Domains

Protein: ENSMUSP00000126161
Gene: ENSMUSG00000078588

Domain	Start	End	E-Value	Type
coiled coil region	13	38	N/A	INTRINSIC

Predicted Effect

probably benign
Transcript: ENSMUST00000153358

SMART Domains

Protein: ENSMUSP00000120571
Gene: ENSMUSG00000028541

Domain	Start	End	E-Value	Type
transmembrane domain	13	35	N/A	INTRINSIC
Pfam:Glyco_transf_7N	94	197	9.5e-33	PFAM

Predicted Effect

probably benign
Transcript: ENSMUST00000167443

SMART Domains

Protein: ENSMUSP00000128771
Gene: ENSMUSG00000028541

Domain	Start	End	E-Value	Type
transmembrane domain	13	35	N/A	INTRINSIC
Pfam:Glyco_transf_7N	94	188	1.1e-24	PFAM

Coding Region Coverage

1x: 99.4%
3x: 98.8%
10x: 97.5%
20x: 95.7%

Validation Efficiency

MGI Phenotype

FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. The enzyme encoded by this gene synthesizes N-acetyllactosamine in glycolipids and glycoproteins. Its substrate specificity is affected by alpha-lactalbumin but it is not expressed in lactating mammary tissue. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2011]
PHENOTYPE: Mice homozygous for a null allele exhibit decreased brain weight, ectopic Purkinje cells in the cerebellum, and impaired spatial learning and coordination. [provided by MGI curators]

Allele List at MGI

Other mutations in this stock

Total: 62 list
Gene	Ref	Var	Chr/Loc	Mutation	Predicted Effect	Zygosity
Ace	A	G	11: 105,861,511 (GRCm39)	Y220C	probably damaging	Het
Actl6a	A	G	3: 32,772,199 (GRCm39)	T170A	probably damaging	Het
Adamts8	T	C	9: 30,867,796 (GRCm39)	V540A	probably benign	Het
Aga	T	C	8: 53,964,919 (GRCm39)	L27P	probably damaging	Het
Agmat	T	A	4: 141,483,134 (GRCm39)	H189Q	probably damaging	Het
Alx3	C	A	3: 107,507,977 (GRCm39)	T162K	probably damaging	Het
Armc2	T	A	10: 41,887,894 (GRCm39)	I30L	possibly damaging	Het
Atp10d	T	G	5: 72,404,552 (GRCm39)	Y487D	probably damaging	Het
Atp13a4	C	T	16: 29,234,649 (GRCm39)	M908I	probably damaging	Het
Bmal1	C	T	7: 112,907,888 (GRCm39)	P530L	probably damaging	Het
Brdt	A	T	5: 107,507,174 (GRCm39)	K525*	probably null	Het
Ccdc168	T	C	1: 44,101,087 (GRCm39)	I4V	probably benign	Het
Ces3a	T	A	8: 105,778,377 (GRCm39)	M246K	probably benign	Het
Chd9	T	A	8: 91,763,190 (GRCm39)	H2338Q	probably damaging	Het
Cyp3a16	T	A	5: 145,389,633 (GRCm39)	D244V	possibly damaging	Het
Dhrs9	C	A	2: 69,224,822 (GRCm39)	A170E	probably damaging	Het
Dlg5	T	C	14: 24,220,529 (GRCm39)	N550D	probably damaging	Het
Dnah8	C	T	17: 31,022,082 (GRCm39)	T3894I	probably damaging	Het
Dpys	T	C	15: 39,705,462 (GRCm39)	H217R	probably damaging	Het
Dpysl2	C	T	14: 67,071,817 (GRCm39)	V108I	probably benign	Het
Eprs1	A	G	1: 185,106,381 (GRCm39)	T199A	probably benign	Het
Fads1	A	G	19: 10,163,767 (GRCm39)	D183G	probably damaging	Het
Fam110b	T	G	4: 5,798,689 (GRCm39)	Y36D	probably damaging	Het
Fbxl21	G	A	13: 56,685,194 (GRCm39)	D407N	probably benign	Het
Fuca2	G	A	10: 13,383,174 (GRCm39)		probably null	Het
Gnas	C	A	2: 174,126,764 (GRCm39)	R100S	probably benign	Het
Gse1	A	G	8: 121,289,416 (GRCm39)	H90R	possibly damaging	Het
Hoxc10	G	T	15: 102,875,702 (GRCm39)	C137F	probably benign	Het
Ipp	T	G	4: 116,377,886 (GRCm39)	L252R	possibly damaging	Het
Jmjd1c	T	A	10: 67,061,857 (GRCm39)	S1403R	probably benign	Het
Kif19a	A	G	11: 114,670,041 (GRCm39)	M79V	probably benign	Het
Lipo4	T	C	19: 33,478,986 (GRCm39)	T285A	possibly damaging	Het
Lrrc66	A	T	5: 73,765,977 (GRCm39)	D355E	probably benign	Het
Lrsam1	T	A	2: 32,835,864 (GRCm39)	Q301L	probably benign	Het
Med6	C	T	12: 81,628,628 (GRCm39)	R138Q	probably damaging	Het
Nlrc5	A	G	8: 95,202,421 (GRCm39)	T174A	probably benign	Het
Nrbp1	C	T	5: 31,406,929 (GRCm39)	R322W	possibly damaging	Het
Or10ak14	T	A	4: 118,610,986 (GRCm39)	T250S	probably benign	Het
Or11g24	C	A	14: 50,662,111 (GRCm39)	A45D	probably benign	Het
Or4a47	T	A	2: 89,666,282 (GRCm39)	E2D	probably benign	Het
Pde3a	A	G	6: 141,429,641 (GRCm39)	E734G	probably damaging	Het
Pgap6	C	T	17: 26,337,846 (GRCm39)	T410I	possibly damaging	Het
Pnpla7	C	T	2: 24,893,013 (GRCm39)	T167I	possibly damaging	Het
Pop7	T	C	5: 137,500,321 (GRCm39)	N4S	possibly damaging	Het
Ppm1h	C	A	10: 122,618,183 (GRCm39)	P114Q	probably benign	Het
Prdm16	T	C	4: 154,426,367 (GRCm39)	T473A	probably benign	Het
Prdm6	T	C	18: 53,669,813 (GRCm39)		probably null	Het
Prkdc	T	G	16: 15,647,633 (GRCm39)	W3686G	possibly damaging	Het
Ptchd4	C	A	17: 42,814,026 (GRCm39)	H642Q	possibly damaging	Het
Rad1	A	G	15: 10,496,009 (GRCm39)	Y228C	possibly damaging	Het
Rgs22	G	A	15: 36,107,101 (GRCm39)	T56I	probably benign	Het
Rnf135	C	A	11: 80,084,733 (GRCm39)	H169N	probably benign	Het
Rnft1	C	T	11: 86,377,319 (GRCm39)	Q128*	probably null	Het
Sez6	T	C	11: 77,864,585 (GRCm39)		probably benign	Het
Sh3rf3	A	G	10: 58,649,769 (GRCm39)	S125G	probably benign	Het
Sik2	T	C	9: 50,826,806 (GRCm39)	E295G	possibly damaging	Het
Themis	A	G	10: 28,739,372 (GRCm39)	Q614R	probably damaging	Het
Thsd7b	T	A	1: 130,044,408 (GRCm39)	C1129*	probably null	Het
Tmem68	A	T	4: 3,569,512 (GRCm39)	F59L	probably benign	Het
Vmn2r107	A	G	17: 20,595,426 (GRCm39)	T660A	probably damaging	Het
Vwa5b2	G	T	16: 20,416,292 (GRCm39)	C484F	probably damaging	Het
Zfp418	T	A	7: 7,184,980 (GRCm39)	C314*	probably null	Het

Other mutations in B4galt2

Allele	Source	Chr	Coord	Type	Predicted Effect	PPH Score
IGL00500:B4galt2	APN	4	117,734,378 (GRCm39)	missense	probably damaging	0.99
IGL02207:B4galt2	APN	4	117,738,718 (GRCm39)	missense	probably damaging	1.00
IGL02224:B4galt2	APN	4	117,734,110 (GRCm39)	missense	probably benign	0.00
IGL02724:B4galt2	APN	4	117,734,075 (GRCm39)	critical splice donor site	probably null
IGL02949:B4galt2	APN	4	117,738,602 (GRCm39)	missense	probably benign	0.05
R1164:B4galt2	UTSW	4	117,734,141 (GRCm39)	missense	possibly damaging	0.96
R1534:B4galt2	UTSW	4	117,734,669 (GRCm39)	missense	probably damaging	1.00
R4715:B4galt2	UTSW	4	117,734,376 (GRCm39)	missense	possibly damaging	0.92
R6492:B4galt2	UTSW	4	117,734,164 (GRCm39)	missense	probably damaging	0.99
R6974:B4galt2	UTSW	4	117,731,148 (GRCm39)	missense	probably damaging	0.98
R7126:B4galt2	UTSW	4	117,734,735 (GRCm39)	missense	probably damaging	1.00
R9220:B4galt2	UTSW	4	117,734,399 (GRCm39)	missense	probably damaging	1.00
R9467:B4galt2	UTSW	4	117,738,123 (GRCm39)	missense	probably damaging	1.00
Z1177:B4galt2	UTSW	4	117,738,266 (GRCm39)	missense	probably benign	0.02

Predicted Primers

PCR Primer
(F):5'- CAACCCTTAGAGCAGCTGTCAG -3'
(R):5'- TTTCTGACTGAAGGGGCTGC -3'

Sequencing Primer
(F):5'- GCAGGCAGCCTTCCATACTAG -3'
(R):5'- CTGCGGTCTTTATTTTGAGAGC -3'

Posted On

2016-11-08